Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 1/20/2026 | N/A | Beyond Air | XAIR | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.70 (0.81) |
-52.35% | Details |
| 1/13/2026 | Michael King Jr. | Telomir Pharma | TELO | New Coverage | Buy (N/A) |
8.00 (N/A) |
1.35 (1.25) |
-7.41% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 64 more... | |||||||||


